Broadening Access to Genomic Testing for Cancer Patients
Battling cancer is extremely challenging because of its impact on the patient’s physical, financial, and mental well-being. A tripartite collaboration...
AstraZeneca
AstraZeneca Progresses Ambition Zero Carbon Programme with Honeywell Partnership to Develop Next-Generation Respiratory Inhalers
AstraZeneca and Honeywell will partner to develop next-generation respiratory inhalers using the propellant HFO-1234ze, which has up to 99.9% less...
AstraZeneca Announces Partnership with Hospitals Beyond Boundaries to Raise Disease Awareness Amongst Youths
AstraZeneca, a global science-led biopharmaceutical company, launched its Young Health Programme through a partnership with Hospitals Beyond Boundaries (HBB), focusing...
Protect Your Heart this World Heart Day
In conjunction with World Heart Day on 29 September, four key industry leaders - AstraZeneca, DoctorOnCall, National Heart Institute (IJN)...
AstraZeneca: Forxiga Approved in Japan for the Treatment of Chronic Kidney Disease in Patients With and Without Type-2 Diabetes
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Japan for the treatment of chronic kidney...
Vaxzevria Showed No Increased Incidence of Thrombosis with Thrombocytopenia After Second Dose
Rates of the very rare clotting disorder, thrombosis with thrombocytopenia syndrome (TTS), following a second dose of Vaxzevria (formerly known...
Vaxzevria and mRNA COVID-19 Vaccines Showed Similar and Favourable Safety Profiles, Study Shows
In a large real-world study, data published as a pre-print on The Lancet server from over one million individuals assessed...
AstraZeneca Delivers 586,700 COVID-19 Vaccine Doses to Malaysia
AstraZeneca delivered 586,700 doses of its COVID-19 vaccine for use in Malaysia. The first batch of shipment from Thailand, which...
AstraZeneca Vaccine’s 12 Weeks Interval Explained
Minister of Science, Technology and Innovation Khairy Jamaluddin announced that the intervals between the first and second doses of the...
Third COVID Vaccine Candidate Starts Phase 3 Trial in US
Today the United States has three COVID-19 vaccine candidates in phase 3 trials, as AstraZeneca launched the final stage of...
